Sudarshan Pharma Industries IPO listing price is ₹ 73.00, issue price is ₹ 73.00, and currently trading at ₹ 29.40 as on May 30, 2025. Sudarshan Pharma Industries IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Sudarshan Pharma Industries IPO is a Book Building listing on BSE SME exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Gretex Corporate Services is the merchant banker of Sudarshan Pharma Industries IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th February 2019.
Sudarshan Pharma Industries IPO offer price is ₹ 73.00 and got listed at ₹ 73.00. Read Sudarshan Pharma Industries IPO details mentioned above.The IPO of Sudarshan Pharma Industries Limited was listed on 22nd March 2023. As of today, Sudarshan Pharma Industries IPO is trading at ₹ 29.40, compared to the previous day’s close of ₹ 29.99. Read the report above for detailed IPO performance.
The issue price of Sudarshan Pharma Industries IPO was ₹ 73.00 per equity share.
Sudarshan Pharma Industries IPO was listed at ₹73.00 on the stock exchange on 22nd March 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Sudarshan Pharma Industries IPO is ₹ 29.40.
The 52-week high for Sudarshan Pharma Industries IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Sudarshan Pharma Industries IPO listed at ₹ 73.00 against the issue price of ₹ 73.00 per equity share, showing a listing day gain/loss of 0 (0.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Sudarshan Pharma Industries IPO stock moved from its listing price of ₹ 73.00 to the current price of ₹29.40 per equity share, reflecting a change of -59.73% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Sudarshan Pharma Industries IPO issue date of May 30, 2025 and CMP of ₹29.40, the estimated CAGR is approximately -33.93%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Sudarshan Pharma Industries IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sudarshan Pharma Industries Financial Review Page
Merchant Banker(s) of Sudarshan Pharma Industries IPO: Gretex Corporate Services Limited
Sudarshan Pharma Industries IPO subscription was 1.06 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sudarshan Pharma Industries IPO listed at a listing price of 73.00 against the offer price of 73.00.
The current market price of Sudarshan Pharma Industries is 29.40.
Why Us?